CAS 853-34-9
:Kebuzone
- 1,2-Diphenyl-4-(2-acetylethyl)pyrazolidine-3,5-dione
- 1,2-Diphenyl-4-(g-ketobutyl)-3,5-pyrazolidinedione
- 212-715-7
- 3,5-Pyrazolidinedione, 4-(3-oxobutyl)-1,2-diphenyl-
- 4-(3-Oxobutyl)-1,2-diphenyl-3,5-pyrazolidinedione
- 4-(3-Oxobutyl)-1,2-diphenylpyrazolidine-3,5-dione
- 853-34-9
- Chebutan
- Chepirol
- Chetazol
- Chetazolidin
- Chetil
- Chetopir
- Copirene
- Gammachetone
- Kebuzone
- Ketanol
- Ketason
- Ketazon
- Ketazone
- Ketophenylbutazone (JAN)
- Pecnon
- Phloguron
- Recheton
- Reuchetal
- γ-Ketazone
- γ-Ketophenylbutazone
- γ-Oxophenylbutazone
- Voir plus de synonymes
KETOPHENYLBUTAZONE
CAS :Formule :C19H18N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :322.3578Ref: IN-DA00G2UE
5mg213,00€10mg219,00€25mg579,00€50mgÀ demander100mgÀ demander2.5mg137,00€250mgÀ demanderKebuzone
CAS :Kebuzone is a non-steroidal anti-inflammatory drug, known to have analgesic, antipyretic, and platelet inhibitory activities.
Formule :C19H18N2O3Couleur et forme :SolidMasse moléculaire :322.36Kebuzone
CAS :Kebuzone is a non-steroidal anti-inflammatory drug that has been used in the treatment of inflammatory bowel disease. The mechanism of action of Kebuzone is as an inhibitor of 5-lipoxygenase, which is responsible for the production of leukotrienes. Kebuzone also inhibits the activity of other enzymes such as cyclooxygenase and lipoxygenase, which are involved in the production of prostaglandins and other inflammatory mediators. In addition to these effects, Kebuzone has been found to be effective against infectious diseases, including malaria. The drug can be administered orally or intravenously and is excreted unchanged by the kidneys following oral administration. It also undergoes extensive metabolism in humans with a metabolic rate that is higher than that reported for most drugs.
Formule :C19H18N2O3Degré de pureté :Min. 95%Couleur et forme :Off-White PowderMasse moléculaire :322.36 g/mol




